Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.56 Million USD | -81.05% |
| 2022 | 13.52 Million USD | 265.34% |
| 2021 | 3.7 Million USD | 211.37% |
| 2020 | 1.18 Million USD | 46.53% |
| 2019 | 811.22 Thousand USD | -14.62% |
| 2018 | 950.1 Thousand USD | -79.3% |
| 2017 | 4.58 Million USD | 208.65% |
| 2016 | 1.48 Million USD | 15.01% |
| 2015 | 1.29 Million USD | -32.23% |
| 2014 | 1.9 Million USD | 118.65% |
| 2013 | 872.43 Thousand USD | 20.54% |
| 2012 | 723.8 Thousand USD | -55.9% |
| 2011 | 1.64 Million USD | -45.46% |
| 2010 | 3 Million USD | 93.69% |
| 2009 | 1.55 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 428.01 Thousand USD | -22.05% |
| 2024 Q2 | 115.68 Thousand USD | -72.97% |
| 2023 FY | 2.56 Million USD | -81.05% |
| 2023 Q1 | 856.48 Thousand USD | -20.24% |
| 2023 Q2 | 618.04 Thousand USD | -27.84% |
| 2023 Q3 | 538.18 Thousand USD | -12.92% |
| 2023 Q4 | 549.09 Thousand USD | 2.03% |
| 2022 Q3 | 7.48 Million USD | 874.19% |
| 2022 FY | 13.52 Million USD | 265.34% |
| 2022 Q1 | 4.19 Million USD | 408.31% |
| 2022 Q2 | 768.19 Thousand USD | -81.69% |
| 2022 Q4 | 1.07 Million USD | -85.65% |
| 2021 Q2 | 391.01 Thousand USD | -26.59% |
| 2021 FY | 3.7 Million USD | 211.37% |
| 2021 Q3 | 416.07 Thousand USD | 6.41% |
| 2021 Q4 | 825.57 Thousand USD | 98.42% |
| 2021 Q1 | 532.6 Thousand USD | 33.52% |
| 2020 Q4 | 398.9 Thousand USD | -0.53% |
| 2020 FY | 1.18 Million USD | 46.53% |
| 2020 Q3 | 401.01 Thousand USD | 114.43% |
| 2020 Q2 | 187.01 Thousand USD | -7.29% |
| 2020 Q1 | 201.73 Thousand USD | -75.05% |
| 2019 Q4 | 808.54 Thousand USD | 338.56% |
| 2019 Q1 | 803.18 Thousand USD | 243.67% |
| 2019 Q2 | 183.4 Thousand USD | -77.17% |
| 2019 Q3 | 184.36 Thousand USD | 0.52% |
| 2019 FY | 811.22 Thousand USD | -14.62% |
| 2018 Q3 | 223.43 Thousand USD | -4.8% |
| 2018 FY | 950.1 Thousand USD | -79.3% |
| 2018 Q4 | 233.7 Thousand USD | 4.6% |
| 2018 Q2 | 234.69 Thousand USD | -9.13% |
| 2018 Q1 | 258.26 Thousand USD | 16.99% |
| 2017 Q1 | 3.85 Million USD | 807.09% |
| 2017 Q2 | 261.23 Thousand USD | -93.22% |
| 2017 Q3 | 253.24 Thousand USD | -3.06% |
| 2017 Q4 | 220.75 Thousand USD | -12.83% |
| 2017 FY | 4.58 Million USD | 208.65% |
| 2016 Q3 | 423.66 Thousand USD | 46.45% |
| 2016 Q4 | 424.84 Thousand USD | 0.28% |
| 2016 FY | 1.48 Million USD | 15.01% |
| 2016 Q1 | 349 Thousand USD | -24.78% |
| 2016 Q2 | 289.28 Thousand USD | -17.11% |
| 2015 Q1 | 214.13 Thousand USD | -20.08% |
| 2015 Q2 | 281.46 Thousand USD | 31.44% |
| 2015 Q3 | 333.17 Thousand USD | 18.37% |
| 2015 Q4 | 464 Thousand USD | 39.27% |
| 2015 FY | 1.29 Million USD | -32.23% |
| 2014 Q1 | 196.31 Thousand USD | -37.65% |
| 2014 Q4 | 267.92 Thousand USD | 3.39% |
| 2014 Q2 | 1.18 Million USD | 503.2% |
| 2014 FY | 1.9 Million USD | 118.65% |
| 2014 Q3 | 259.13 Thousand USD | -78.12% |
| 2013 Q3 | 187.48 Thousand USD | 10.23% |
| 2013 Q2 | 170.09 Thousand USD | -39.93% |
| 2013 Q1 | 283.17 Thousand USD | 240.8% |
| 2013 FY | 872.43 Thousand USD | 20.54% |
| 2013 Q4 | 314.86 Thousand USD | 67.94% |
| 2012 Q3 | 218.82 Thousand USD | 123.92% |
| 2012 Q2 | 97.72 Thousand USD | -69.85% |
| 2012 Q4 | 83.09 Thousand USD | -62.03% |
| 2012 FY | 723.8 Thousand USD | -55.9% |
| 2012 Q1 | 324.16 Thousand USD | 31.39% |
| 2011 Q4 | 246.71 Thousand USD | -16.29% |
| 2011 FY | 1.64 Million USD | -45.46% |
| 2011 Q3 | 294.74 Thousand USD | -58.21% |
| 2011 Q2 | 705.36 Thousand USD | 78.85% |
| 2011 Q1 | 394.39 Thousand USD | 24.33% |
| 2010 Q2 | 1.36 Million USD | 184.87% |
| 2010 FY | 3 Million USD | 93.69% |
| 2010 Q4 | 317.21 Thousand USD | -62.76% |
| 2010 Q3 | 851.87 Thousand USD | -37.4% |
| 2010 Q1 | 477.7 Thousand USD | 6.8% |
| 2009 Q1 | 283.59 Thousand USD | 0.0% |
| 2009 Q4 | 447.27 Thousand USD | 25.68% |
| 2009 Q2 | 358.26 Thousand USD | 26.33% |
| 2009 FY | 1.55 Million USD | 0.0% |
| 2009 Q3 | 355.89 Thousand USD | -0.66% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 10.531% |
| Ansell Limited | 495.5 Million USD | 99.483% |
| Ansell Limited | 495.5 Million USD | 99.483% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 96.906% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -48.016% |
| Psykey, Inc. | 1.21 Million USD | -111.112% |
| ConvaTec Group Plc | 910.31 Million USD | 99.719% |
| ConvaTec Group Plc | 872.5 Million USD | 99.706% |
| Encision Inc. | 3.77 Million USD | 32.169% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -1706.492% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -2230.375% |
| Innovative MedTech Inc. | 6.09 Million USD | 57.996% |
| LifePoint, Inc. | 7.42 Million USD | 65.492% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 59.65% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -199.626% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -252.8% |
| Reflect Scientific, Inc. | 1.06 Million USD | -140.839% |
| SmileDirectClub, Inc. | 517 Million USD | 99.504% |
| Sector 10, Inc. | 39.84 Thousand USD | -6329.585% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.961% |
| SheerVision, Inc. | 2.33 Million USD | -9.872% |
| United Health Products, Inc. | 2.42 Million USD | -5.574% |
| Vasamed, Inc. | 4.67 Million USD | 45.178% |
| Yubo International Biotech Limited | 1.25 Million USD | -103.661% |